XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Total Snowflake Inc. Stockholders’ Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest
Beginning balance (in shares) at Jan. 31, 2022     312,377,000          
Beginning balance at Jan. 31, 2022 $ 5,049,045 $ 5,049,045 $ 31 $ 0 $ 6,984,669 $ (16,286) $ (1,919,369) $ 0
Beginning balance, treasury stock (in shares) at Jan. 31, 2022       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     3,942,000          
Issuance of common stock upon exercise of stock options 23,567 23,567 $ 1   23,566      
Issuance of common stock under employee stock purchase plan (in shares)     184,000          
Issuance of common stock under employee stock purchase plan 26,094 26,094     26,094      
Issuance of common stock in connection with a business combination (in shares)     1,914,000          
Issuance of common stock in connection with a business combination 438,916 438,916     438,916      
Issuance of common stock in connection with a business combination subject to future vesting (in shares)     409,000          
Vesting of early exercised stock options 122 122     122      
Vesting of restricted stock units (in shares)     1,623,000          
Shares withheld related to net share settlement of equity awards (in shares)     (552,000)          
Shares withheld related to net share settlement of equity awards (86,134) (86,134)     (86,134)      
Stock-based compensation 394,884 394,884     394,884      
Other comprehensive income (loss) (31,571) (31,571)       (31,571)    
Net loss (388,600) (388,600)         (388,600)  
Ending balance (in shares) at Jul. 31, 2022     319,897,000          
Ending balance at Jul. 31, 2022 5,426,323 5,426,323 $ 32 $ 0 7,782,117 (47,857) (2,307,969) 0
Ending balance, treasury stock (in shares) at Jul. 31, 2022       0        
Beginning balance (in shares) at Apr. 30, 2022     317,814,000          
Beginning balance at Apr. 30, 2022 5,457,994 5,457,994 $ 32 $ 0 7,589,712 (46,587) (2,085,163) 0
Beginning balance, treasury stock (in shares) at Apr. 30, 2022       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     1,494,000          
Issuance of common stock upon exercise of stock options 8,437 8,437     8,437      
Issuance of common stock in connection with a business combination (in shares)     74,000          
Vesting of early exercised stock options 61 61     61      
Vesting of restricted stock units (in shares)     775,000          
Shares withheld related to net share settlement of equity awards (in shares)     (260,000)          
Shares withheld related to net share settlement of equity awards (31,989) (31,989)     (31,989)      
Stock-based compensation 215,896 215,896     215,896      
Other comprehensive income (loss) (1,270) (1,270)       (1,270)    
Net loss (222,806) (222,806)         (222,806)  
Ending balance (in shares) at Jul. 31, 2022     319,897,000          
Ending balance at Jul. 31, 2022 5,426,323 5,426,323 $ 32 $ 0 7,782,117 (47,857) (2,307,969) 0
Ending balance, treasury stock (in shares) at Jul. 31, 2022       0        
Beginning balance (in shares) at Jan. 31, 2023     323,305,000          
Beginning balance at Jan. 31, 2023 $ 5,468,615 5,456,436 $ 32 $ 0 8,210,750 (38,272) (2,716,074) 12,179
Beginning balance, treasury stock (in shares) at Jan. 31, 2023 0     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares) 2,376,000              
Ending balance (in shares) at Apr. 30, 2023     326,312,000          
Ending balance at Apr. 30, 2023 $ 5,297,985 5,286,243 $ 33 $ (68,299) 8,450,433 (30,828) (3,065,096) 11,742
Ending balance, treasury stock (in shares) at Apr. 30, 2023       (500,000)        
Beginning balance (in shares) at Jan. 31, 2023     323,305,000          
Beginning balance at Jan. 31, 2023 $ 5,468,615 5,456,436 $ 32 $ 0 8,210,750 (38,272) (2,716,074) 12,179
Beginning balance, treasury stock (in shares) at Jan. 31, 2023 0     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     4,856,000          
Issuance of common stock upon exercise of stock options $ 31,527 31,527 $ 1   31,526      
Issuance of common stock under employee stock purchase plan (in shares)     312,000          
Issuance of common stock under employee stock purchase plan 37,065 37,065     37,065      
Vesting of early exercised stock options 122 122     122      
Vesting of restricted stock units (in shares)     3,499,000          
Shares withheld related to net share settlement of equity awards (in shares)     (1,189,000)          
Shares withheld related to net share settlement of equity awards $ (188,905) (188,905)     (188,905)      
Repurchases of common stock (in shares) (500,000)     (500,000)        
Repurchases of common stock as treasury stock $ (68,299) (68,299)   $ (68,299)        
Repurchases and retirement of common stock (in shares)     (905,000)          
Repurchases and retirement of common stock (123,395) (123,395)         (123,395)  
Stock-based compensation 588,853 588,853     588,853      
Other comprehensive income (loss) 6,028 6,028       6,028    
Net loss (453,384) (452,494)         (452,494) (890)
Ending balance (in shares) at Jul. 31, 2023     329,878,000          
Ending balance at Jul. 31, 2023 $ 5,298,227 5,286,938 $ 33 $ (68,299) 8,679,411 (32,244) (3,291,963) 11,289
Ending balance, treasury stock (in shares) at Jul. 31, 2023 (500,000)     (500,000)        
Beginning balance (in shares) at Apr. 30, 2023     326,312,000          
Beginning balance at Apr. 30, 2023 $ 5,297,985 5,286,243 $ 33 $ (68,299) 8,450,433 (30,828) (3,065,096) 11,742
Beginning balance, treasury stock (in shares) at Apr. 30, 2023       (500,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares) 2,480,000   2,480,000          
Issuance of common stock upon exercise of stock options $ 16,194 16,194     16,194      
Vesting of early exercised stock options 61 61     61      
Vesting of restricted stock units (in shares)     1,637,000          
Shares withheld related to net share settlement of equity awards (in shares)     (551,000)          
Shares withheld related to net share settlement of equity awards (99,902) (99,902)     (99,902)      
Stock-based compensation 312,625 312,625     312,625      
Other comprehensive income (loss) (1,416) (1,416)       (1,416)    
Net loss (227,320) (226,867)         (226,867) (453)
Ending balance (in shares) at Jul. 31, 2023     329,878,000          
Ending balance at Jul. 31, 2023 $ 5,298,227 $ 5,286,938 $ 33 $ (68,299) $ 8,679,411 $ (32,244) $ (3,291,963) $ 11,289
Ending balance, treasury stock (in shares) at Jul. 31, 2023 (500,000)     (500,000)